Second generation aniten compound (Essa Pharma)

N/A

Report date: 2025/01/26 16:12:04
NME

Base Information

Drug NameSecond generation aniten compound (Essa Pharma)
Drug Alias NameAndrogen receptor antagonist (Essa Pharma)Second generation aniten compound (Essa Pharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor degraders
TargetsAndrogen Receptor
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEssa Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesEssa Pharma Inc
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A